Company profile: Cerba HealthCare
1.1 - Company Overview
Company description
- Provider of routine and specialized clinical pathology and in vitro diagnostic testing, including support for clinical trials; anatomo-cytopathology for cellular and tissue diagnosis; veterinary clinical pathology for animal health; and medical imaging services such as X-rays, MRIs, and CT scans.
Products and services
- Specialized Clinical Pathology: Delivers advanced-grade in vitro diagnostic tests for complex and rare diseases, leveraging specialized clinical laboratory testing services to produce accurate interpretations used in precise disease diagnosis
- Routine Clinical Pathology: Supplies standard-grade laboratory tests for diagnosing and monitoring common health conditions, delivering routine clinical pathology services with in vitro assessments that support ongoing patient management
- Clinical Pathology for Clinical Trials: Offers trial-grade laboratory testing services to support clinical trials by ensuring accurate and reliable data generation through in vitro testing for study endpoints
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cerba HealthCare
Memorial MRI & Diagnostic
HQ: United States
Website
- Description: Provider of diagnostic imaging and treatment services, offering MRI, PET-CT, CT cat scans, ultrasound (including 3D/4D), x-ray, nuclear medicine, mammography, bone density services, EMG and NVC, and pain management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Memorial MRI & Diagnostic company profile →
Avero Diagnostics
HQ: United States
Website
- Description: Provider of physician-operated laboratory services in anatomic, molecular, and clinical pathology with a focus on women’s health and subspecialized expertise in breast, gynecologic, gastrointestinal, dermatologic, hematologic, surgical, and urologic pathology. Offers molecular tests (Chlamydia, Gonorrhoeae, HPV, COVID-19), broad clinical diagnostics, a Pap Support Program, and EMR/LIS and online reporting via Avero Connect and Avero Link.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avero Diagnostics company profile →
Poplar Healthcare
HQ: United States
Website
- Description: Provider of specialized laboratory testing services through its GI Pathology, D-PATH Dermatopathology, OncoMetrix, UroPath Diagnostics, and Women’s Health Laboratories brands, serving a nationwide client base of gastroenterologists, dermatologists, oncologists, and urologists.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Poplar Healthcare company profile →
Pathology Laboratory Associates
HQ: United States
Website
- Description: Provider of on-site Next Generation Sequencing to identify mutations in solid tumors, aiding personalized therapy decisions, and pathology services including anatomic pathology, dermatopathology, hematopathology, molecular pathology, and neuropathology, built on Pathology Laboratory Associates' expertise and Synergy's recognized leadership in medical testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pathology Laboratory Associates company profile →
Dermpath Lab
HQ: United States
Website
- Description: Provider of dermatopathology laboratory and physician consultation services with expertise in molecular studies and testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dermpath Lab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cerba HealthCare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cerba HealthCare
2.2 - Growth funds investing in similar companies to Cerba HealthCare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cerba HealthCare
4.2 - Public trading comparable groups for Cerba HealthCare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →